|
| Status |
Public on May 31, 2018 |
| Title |
Next Generation Sequencing Facilitates Quantitative Analysis of PVT1 mutant alleles have distinct growth advatage which was introduced by CRISPR in MDA-MB-231 human breast cancer cell line |
| Organism |
Homo sapiens |
| Experiment type |
Other
|
| Summary |
PVT1 deletion alleles have growth adavatage after 10 passages
|
| |
|
| Overall design |
Comapare allele frequency between passage 0 and 10 in competitive growth by two independent Cas9-sgRNA RNP transfection
|
| |
|
| Contributor(s) |
Cho SW, Chang HY |
| Citation(s) |
29731168 |
| Submission date |
Apr 10, 2017 |
| Last update date |
May 15, 2019 |
| Contact name |
Howard Y. Chang |
| E-mail(s) |
howchang@stanford.edu
|
| Phone |
650-725-7022
|
| Organization name |
Stanford
|
| Lab |
Chang Lab
|
| Street address |
269 Campus Drive, CCSR 2130
|
| City |
Stanford |
| State/province |
CALIFORNIA |
| ZIP/Postal code |
94305 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
| Samples (5)
|
| GSM2572602 |
PVT1 targeting sgRNA R2 rep1 passage 10 |
| GSM2572603 |
PVT1 targeting sgRNA R2 rep2 passage 10 |
|
| This SubSeries is part of SuperSeries: |
| GSE97669 |
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element |
|
| Relations |
| BioProject |
PRJNA382391 |
| SRA |
SRP103778 |
Less...
More...